- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on B Cell Chronic Lymphocytic Leukemia in United Kingdom
Total 4234 results
-
Gilead SciencesCompletedChronic Lymphocytic LeukemiaUnited States, France, United Kingdom, Germany, Italy
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedReduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationChronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Innate PharmaTerminatedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.; OSI PharmaceuticalsCompletedChronic Lymphocytic LeukemiaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); FDA Office of Orphan Products DevelopmentCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Boston Medical CenterCompleted
-
Memgen, LLCCompleted
-
Memgen, LLCCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedStage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Monoclonal B-Cell Lymphocytosis | Stage I Small Lymphocytic LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedChronic Lymphocytic Leukemia With 17p Deletion | Small Lymphocytic Lymphoma With 17p DeletionUnited States, United Kingdom, Belgium, Germany, Turkey, Australia, Canada, New Zealand, Sweden
-
Duke UniversityCompletedAging | Chronic Lymphocytic LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Thomas KippsBayerTerminatedChronic Lymphocytic LeukemiaUnited States
-
Bristol-Myers SquibbWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedStage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | Lymphoid Leukemia in RemissionUnited States
-
AbbVie (prior sponsor, Abbott)CompletedAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | B-cell Chronic Lymphocytic Leukemia | MyelodysplasiaUnited States
-
Daphne FriedmanKeryx Biopharmaceuticals; Keryx / AOI Pharmaceuticals, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.TerminatedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedIdentifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)Leukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Lymphocytic LeukemiaUnited States
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompletedLeukemia | Chronic Lymphocytic Leukemia | Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBayerCompletedLeukemiaUnited States
-
Massachusetts General HospitalBristol-Myers Squibb; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Dana-Farber Cancer InstituteGenzyme, a Sanofi CompanyCompletedChronic Lymphocytic LeukemiaUnited States
-
University of PittsburghGenentech, Inc.; BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
John HaslipCompleted
-
M.D. Anderson Cancer CenterBayerCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterBerlex Laboratories, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
University of KentuckyCephalonWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Afexa Life Sciences IncWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Genta IncorporatedCompletedChronic Lymphocytic LeukemiaUnited States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompletedChronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Completed